Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis |
Relapsing Multiple Sclerosis | Germany | NCT05344469 | |
Remibrutinib in Real-world Clinical Practice - a US Sub-study |
Chronic Spontaneous Urticaria | United States | NCT07358780 | |
A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients |
Chronic Spontaneous Urticaria | United States | NCT07408219 | |
Remibrutinib in Real-world Clinical Practice |
Chronic Spontaneous Urticaria | United States | NCT07358364 | |
Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world Practice |
Breast Cancer | Russia | NCT06905301 | |
Real-world Secukinumab Outcomes in Canadian HS Patients |
Hidradenitis Suppurativa | Canada | NCT07282015 | |
Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia |
Atherosclerotic Cardiovascular Disease | Phase4 | United Arab Emirates | NCT07034690 |
Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab |
Primary Immune Thrombocytopenia, Warm Autoimmune Hemolytic Anemia | Phase2 | Belgium China Czechia Germany Hungary Italy Malaysia Singapore Spain Turkey (Türkiye) United Kingdom View all |
NCT07039422 |
A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer |
Metastatic Prostate Cancer (mCRPC) | Phase1 | Japan | NCT07174063 |
Ilaris NIS in Korea |
Hereditary Periodic Fever Syndromes, Cryopyrin-associated Periodic Syndromes (CAPS), Colchicine Resistance Familial Mediterranean Fever (crFMF), TNF Receptor Associated Periodic Syndrome (TRAPS), Hyper-IgD Syndrome / Mevalonate Kinase Deficiency (HIDS/MKD), Systemic Juvenile Idiopathic Arthritis (sJIA) | South Korea | NCT06838143 |